Friday, May 1, 2026

JW Pharmaceutical Secures Phase 1 Approval for Novel Hair Loss Treatment JW0061—What to Expect?

JW Pharmaceutical is investing in innovative hair loss treatments and expanding its drug portfolio, including successful cholesterol medications.

MARKET FREEDOM! Trump KILLS Biden’s EV Dreams, Unleashing $109 Billion In Savings: This Is America!

Trump announced plans to relax fuel economy regulations for new cars, targeting an average of 50 miles per gallon by 2031.

How JNPMEDI Plans to Achieve 250% Revenue Growth in 2026: A Guide for Pharma Innovators

JNPMEDI aims to enhance its global role in drug and medical device development, achieving significant growth and expanding partnerships.

Soo Yeon Yoo

No posts to display

Top News

- Our Sponsors Ad -

Follow us